Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

Katalin Gulyas, Nora Bodnar, Zsofia Nagy, Szilvia Szamosi, Agnes Horvath, Andrea Vancsa, Edit Vegh, Zoltan Szabo, Gabriella Szucs, Zoltan Szekanecz and Sandor Szanto ()

The European Journal of Health Economics, 2014, vol. 15, issue 1, 93-100

Abstract: Although the retention rate to a second-line TNFi was somewhat worse than that to the first-line TNFi, the switching of TNFis is a good therapeutic option in AS patients who failed to respond to the first TNFi. Copyright Springer-Verlag Berlin Heidelberg 2014

Keywords: Ankylosing spondylitis; Anti-tumour necrosis factor-α therapy; Switch; I190 (search for similar items in EconPapers)
Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1007/s10198-014-0598-0 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:15:y:2014:i:1:p:93-100

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-014-0598-0

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().